Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Polycythemia Vera 1Neoplasms 1Multi-centric Castleman's Disease 1Melanoma 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphadenopathy 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1HIV Infections 1

Interventions

Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Fluorouracil 2Etoposide 2Cyclophosphamide 2Biopsy 2liposomal doxorubicin 1fludarabine 1dehydroftorafur 1carmustine, poliferprosan 20 drug combination 1cabozantinib 1axicabtagene ciloleucel 1Zidovudine 1X-Rays 1Vincristine 1Valganciclovir 1Triage 1Therapeutics 1Standard of Care 1Sodium Chloride 1Smoking Devices 1Sirolimus 1Sigmoidoscopy 1Sentinel Lymph Node Biopsy 1Rituximab 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Proctoscopy 1Prednisone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
HIV Infections × Interferon-alpha × 1 year × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡